Ultragenyx Pharmaceutical Inc. (RARE)
NMS – Real vaqt narxi. Valyuta: USD
26.86
-0.10 (-0.37%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
26.99
+0.13 (0.48%)
Bozordan keyin: Aug 12, 2026, 4:38 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
26.86
-0.10 (-0.37%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
26.99
+0.13 (0.48%)
Bozordan keyin: Aug 12, 2026, 4:38 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $1.2B naqd pul zahiralaridan ($134.0M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $606.0M jami joriy majburiyatlardan $351.0M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-4.2) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-3.4x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$98.0M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.73 | 6.05 | 8.0 | |
| Tezkor likvidlik nisbati | 1.56 | 5.63 | 8.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.95 | 1.04 | 2.0 | |
| Foiz to‘lov qoplami | -3.41 | -16.91 | 1.0 | |
| O‘rtacha ball | 4.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 363M | 434M | 560M | 673M | 717M |
| Yalpi foyda | 320M | 367M | 453M | 537M | 563M |
| Operatsion daromad | -649M | -569M | -536M | -535M | -529M |
| Sof foyda | -707M | -607M | -569M | -575M | -586M |
| EBITDA | -631M | -543M | -500M | -500M | -495M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 15.01 | 44.39 | 9.5 |
| Keyingi chorak | 7.15 | 60.78 | 7.5 |
| Joriy yil | 11.33 | 26.74 | 8.5 |
| Keyingi yil | 32.64 | 83.19 | 10 |
| O‘rtacha ball | 8.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 57.35 | 50.27 | 51.09 | 50.51 | 10 |
| Yil/Yil | 28.53 | 19.97 | 23.08 | 11.5 | 9.0 |
| 3 yil o‘rtacha | 22.89 | 6.47 | 16.52 | 0.77 | 6.5 |
| 5 yil o‘rtacha | 20.34 | -35.94 | -23.93 | -30.4 | 3.3 |
| O‘rtacha ball | 7.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |